The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
Notifications can be managed in browser preferences.
Swipe for next article
The new medication is suitable for patients who are unable to receive chemotherapy or standard treatments
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Men with high-risk prostate cancer that has not yet spread now qualify for the treatment
NHS-backed programme will give men rapid access to new treatments for the best chance of a ‘longer, healthier life’
Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit
Trial will inform future population-wide prostate cancer screening programmes for men
Personalised immunotherapy can keep disease at bay for more than four years
It is estimated that 1,250 people a year could benefit from the new drug
